Most recently, it has been identified that conolidine and the above mentioned derivatives act about the atypical chemokine receptor three (ACKR3. Expressed in equivalent parts as classical opioid receptors, it binds to the wide array of endogenous opioids. Compared with most opioid receptors, this receptor acts like a scavenger and would not activa